Overall rank by patents
#739
Across all tracked assignees
USPTO PatentsView assignee record - 617 granted patents across 77 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B81B (MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES).
The verdict
Invensense holds 617 US patents across 77 technology areas, rank #739 of 50,000 tracked assignees.
Invensense, Inc. has been granted 617 US utility patents between 2015 and 2025, placing Invensense, Inc. at rank #739 across all assignees tracked by PlainPatent. This portfolio spans 77 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.4 claims per patent with primary concentration in B81B (MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES). As a US Corporation, Invensense, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Invensense sits between Siemens Energy Global Gmbh & Co. KG (620 patents, rank #735) and Fresenius Medical Care Deutschland Gmbh (615 patents, rank #743) - the closest US assignees by grant volume. The composite Innovation Score of 64.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 288 grants, compared with 329 in the 2015–2019 window, a -12% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Invensense, Inc.'s 21.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 77 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Invensense, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Siemens Energy Global GmbH & Co. KG
620 patents
HITACHI KOKUSAI ELECTRIC INC.
618 patents
Semes Co., Ltd.
618 patents
Institut National de la Sante et de la Recherche Medicale (INSERM)
617 patents
InvenSense, Inc.
617 patents
Bell Helicopter Textron Inc.
616 patents
SUZUKI MOTOR CORPORATION
616 patents
UCHICAGO ARGONNE, LLC
616 patents
Fresenius Medical Care Deutschland GmbH
615 patents
What this shows Invensense holds 617 patents at rank #739, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #739 in granted patent volume.
Other assignees with the most granted patents in Invensense's primary technology class.
Invensense's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
64 Top 2% higher than 98% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 49 | 7.9% |
| 2016 | 51 | 8.3% |
| 2017 | 83 | 13.5% |
| 2018 | 59 | 9.6% |
| 2019 | 87 | 14.1% |
| 2020 | 76 | 12.3% |
| 2021 | 57 | 9.2% |
| 2022 | 50 | 8.1% |
| 2023 | 46 | 7.5% |
| 2024 | 33 | 5.3% |
| 2025 | 26 | 4.2% |
Top 15 of 77 technology areas
Overall rank by patents
#739
Across all tracked assignees
64.0 out of 100
How to use this portfolio
Invensense's 617 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.